Showing results (11-20 of 211) with videos related to
Sort By:
Pageof 22
Critical Care Medicine|June 1, 1995
Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double-blind trialS M Willatts, S Radford, M LeitermannAnaesthesia|June 1, 1983
Training in intensive care. A questionnaire to traineesK Hillman, C J Hinds, S M WillattsAnaesthesia|December 1, 1995
Health and activity after intensive careJ Munn, S M Willatts, M A TooleyAnesthesia and Analgesia|December 1, 1991
Plasma inorganic fluoride concentrations during and after prolonged (greater than 24 h) isoflurane sedation: effect on renal functionE M Spencer, S M Willatts, C Prys-RobertsJournal of the Royal Society of Medicine|February 1, 1994
APACHE II scoring system on a general intensive care unit: audit of daily APACHE II scores and 6-month survival of 691 patients admitted to a general intensive care unit between May 1990 and December 1991N N Campbell, M A Tooley, S M WillattsAnaesthesia|September 1, 1994
Incidence of gram-negative bacteraemia in sepsis syndrome. Implications for immunotherapyS M Willatts, D C Speller, R J WinterBritish Journal of Anaesthesia|November 1, 1994
Continuous monitoring of depth of sedation by EEG spectral analysis in patients requiring mechanical ventilationE M Spencer, J L Green, S M WillattsBMJ (Clinical Research Ed.)|May 13, 1989
Isoflurane compared with midazolam for sedation in the intensive care unitK L Kong, S M Willatts, C Prys-RobertsAlimentary Pharmacology & Therapeutics|November 9, 2002
Review article: albumin as a drug--biological effects of albumin unrelated to oncotic pressureT W EvansBritish Journal of Anaesthesia|February 1, 1990
Isoflurane sedation for patients undergoing mechanical ventilation: metabolism to inorganic fluoride and renal effectsK L Kong, J E Tyler, S M Willatts, et al.Pageof 22